loading
Pacific Biosciences Of California Inc stock is traded at $1.6094, with a volume of 301.20K. It is down -1.52% in the last 24 hours and up +25.19% over the past month. Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
See More
Previous Close:
$1.64
Open:
$1.63
24h Volume:
301.20K
Relative Volume:
0.03
Market Cap:
$481.64M
Revenue:
$188.87M
Net Income/Loss:
$-400.38M
P/E Ratio:
-1.0729
EPS:
-1.5
Net Cash Flow:
$-260.90M
1W Performance:
-0.31%
1M Performance:
+25.19%
6M Performance:
+3.53%
1Y Performance:
-21.22%
1-Day Range:
Value
$1.605
$1.64
1-Week Range:
Value
$1.50
$1.71
52-Week Range:
Value
$0.8511
$2.72

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Name
Pacific Biosciences Of California Inc
Name
Phone
650-521-8000
Name
Address
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Employee
575
Name
Twitter
@pacbio
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
PACB's Discussions on Twitter

Compare PACB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
PACB
Pacific Biosciences Of California Inc
1.605 462.13M 188.87M -400.38M -260.90M -1.50
Medical Devices icon
ABT
Abbott Laboratories
125.92 220.16B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.67 157.03B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
401.81 154.21B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.91 119.08B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
79.33 46.93B 5.69B 4.15B 623.10M 6.95

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-11-24 Downgrade UBS Buy → Neutral
Jun-03-24 Resumed Jefferies Buy
Apr-22-24 Downgrade JP Morgan Overweight → Neutral
Apr-18-24 Downgrade Goldman Buy → Neutral
Dec-14-23 Initiated Guggenheim Neutral
Dec-14-23 Initiated Stephens Overweight
Dec-13-23 Initiated Wolfe Research Peer Perform
Nov-17-23 Upgrade UBS Neutral → Buy
Oct-31-23 Upgrade Cantor Fitzgerald Neutral → Overweight
Sep-28-23 Initiated Bernstein Outperform
Jul-05-23 Resumed JP Morgan Overweight
Jun-30-23 Initiated Goldman Buy
May-10-23 Initiated Barclays Equal Weight
Mar-31-23 Upgrade TD Cowen Market Perform → Outperform
Feb-02-23 Initiated UBS Neutral
Jan-20-23 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-05-23 Initiated Scotiabank Sector Outperform
Jan-21-22 Resumed Cantor Fitzgerald Overweight
Jan-06-22 Resumed Piper Sandler Neutral
Oct-15-21 Resumed Cowen Market Perform
Sep-27-21 Initiated Canaccord Genuity Buy
Feb-11-21 Upgrade Piper Sandler Neutral → Overweight
Nov-03-20 Downgrade Piper Sandler Overweight → Neutral
Oct-02-20 Upgrade JP Morgan Neutral → Overweight
Sep-09-20 Initiated Morgan Stanley Equal-Weight
Jun-02-20 Resumed Cantor Fitzgerald Overweight
Mar-09-20 Resumed Cantor Fitzgerald Overweight
Oct-15-19 Upgrade Piper Jaffray Neutral → Overweight
Apr-02-19 Downgrade Stephens Overweight → Equal-Weight
Oct-19-18 Initiated Cowen Outperform
Nov-03-17 Downgrade First Analysis Sec Overweight → Equal-Weight
Sep-28-17 Downgrade CL King Buy → Neutral
Nov-03-16 Reiterated Cantor Fitzgerald Buy
Jun-27-16 Initiated CL King Buy
Apr-15-16 Initiated First Analysis Sec Overweight
Feb-04-16 Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16 Reiterated Cantor Fitzgerald Buy
Oct-23-15 Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15 Initiated Cantor Fitzgerald Buy
Feb-04-15 Reiterated Maxim Group Buy
Sep-26-13 Reiterated Maxim Group Buy
Jan-14-13 Reiterated Maxim Group Buy
View All

Pacific Biosciences Of California Inc Stock (PACB) Latest News

pulisher
07:04 AM

Is Pacific Biosciences of California (NASDAQ:PACB) A Risky Investment? - simplywall.st

07:04 AM
pulisher
Jul 28, 2025

These 10 Stocks are Winning Big - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

Wyckoff Accumulation Phase Possible in Pacific Biosciences of California Inc.Entry Points For Growing Stocks Identified by Models - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Pacific Biosciences of California Inc. stockBuild a winning investment portfolio - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Pacific Biosciences of California Inc. company’s growth strategyMaximize your portfolio’s growth potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Pacific Biosciences of California Inc. a growth stock or a value stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Pacific Biosciences of California Inc. generate profit in a changing economyCapitalize on proven trading setups - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Why is Pacific Biosciences of California Inc. stock attracting strong analyst attentionBuild wealth steadily with smart stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Pacific Biosciences of California Inc. company’s balance sheetInvest smarter with expert stock recommendations - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Pacific Biosciences of California Inc. in the next 12 monthsRealize exceptional returns through smart trading - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN

Jul 27, 2025
pulisher
Jul 25, 2025

What makes Pacific Biosciences of California Inc. stock attractive to long term investorsExplosive capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Pacific Biosciences shares rise 1.30% premarket after announcing significant advancement in genomic sequencing. - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Pacific Biosciences of California Inc. Stock Analysis and ForecastExplosive returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

PacBio (PACB) Technology Powers Significant Genomic Research in Arab Populations | PACB Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - Yahoo.co

Jul 24, 2025
pulisher
Jul 24, 2025

Publication spotlight: How Kinnex long-read RNA sequencing wins out over Illumina for transcript-level quantification - PacBio

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Pacific Biosciences of California Inc. stockExceptional earning trajectories - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Intrinsic Value Is Potentially 41% Above Its Share Price - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

Why PacBio (PACB) Stock Is Up Today - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

QIAGEN’s New Sequencing Panels Boosts PacBio Expansion - StocksToTrade

Jul 23, 2025
pulisher
Jul 23, 2025

Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

PacBio Joins 1000 Genomes Long Read Sequencing Project to Enhance Human Genomics Research - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Is Pacific Biosciences of California Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

QIAGEN Expands NGS Portfolio with QIAseq xHYB Long Read Panels - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Pacific Biosciences of California Inc. stock priceRapid capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

PacBio (PACB) Collaborates with Qiagen for Enhanced Genomic Insi - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN launches long-read sequencing panels for complex genomic regions By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

PACB Stock Rally: Bullish Signs or Temporary Spike? - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 17:54:31 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

DNA Sequencing Leader PacBio Sets Q2 2025 Earnings Release Date: What Analysts Are Watching - Stock Titan

Jul 21, 2025

Pacific Biosciences Of California Inc Stock (PACB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pacific Biosciences Of California Inc Stock (PACB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
HENRY CHRISTIAN O
See Remarks
Mar 03 '25
Sale
1.41
12,497
17,583
2,225,357
Van Oene Mark
See Remarks
Mar 03 '25
Sale
1.41
6,486
9,126
1,497,695
Farmer Michele
See Remarks
Mar 03 '25
Sale
1.41
2,973
4,183
184,619
$291.86
price down icon 0.14%
medical_devices STE
$225.90
price down icon 0.23%
medical_devices PHG
$28.20
price up icon 10.28%
$89.22
price down icon 0.11%
$78.14
price up icon 0.64%
medical_devices EW
$79.26
price up icon 0.98%
Cap:     |  Volume (24h):